Selected research
Industry Growth & Trends
Global AI Drug Target Discovery Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI Drug Target Discovery Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI Drug Target Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI Drug Target Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Drug Target Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI Drug Target Discovery Service market include Exscientia, Atomwise, Benevolent AI, Insitro, Xaira Therapeutics, Tempus AI, AbCellera, Recursion and Iktos, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI Drug Target Discovery Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI Drug Target Discovery Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Drug Target Discovery Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Drug Target Discovery Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI Drug Target Discovery Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI Drug Target Discovery Service Market by Company
Exscientia
Atomwise
Benevolent AI
Insitro
Xaira Therapeutics
Tempus AI
AbCellera
Recursion
Iktos
Genialis
Anima Biotech
BPGbio
Cradle
Isomorphic Labs
Generate Biomedicines
Latent Labs
Relay Therapeutics
Model Medicines
Nimbus Therapeutics
Schrödinger
XtalPi
Insilico Medicine
Drug Farm
BioMap
AI Drug Target Discovery Service Segment by Type
Target Identification Based on Omics Data and Biological Networks
Target Mining Based on Literature and Knowledge Graphs
Target Prediction Based on Structural Bioinformatics
Target Discovery Based on Phenotypic Screening and Virtual Patients
AI Drug Target Discovery Service Segment by Application
Pharmaceutical Company
CRO and Universities
Others
AI Drug Target Discovery Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Target Discovery Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Drug Target Discovery Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Target Discovery Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI Drug Target Discovery Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Target Identification Based on Omics Data and Biological Networks
- Target Mining Based on Literature and Knowledge Graphs
- Target Prediction Based on Structural Bioinformatics
- Target Discovery Based on Phenotypic Screening and Virtual Patients
Applications
- Pharmaceutical Company
- CRO and Universities
- Others
Companies covered
- Exscientia
- Atomwise
- Benevolent AI
- Insitro
- Xaira Therapeutics
- Tempus AI
- AbCellera
- Recursion
- Iktos
- Genialis
- Anima Biotech
- BPGbio
- Cradle
- Isomorphic Labs
- Generate Biomedicines
- Latent Labs
- Relay Therapeutics
- Model Medicines
- Nimbus Therapeutics
- Schrödinger
- XtalPi
- Insilico Medicine
- Drug Farm
- BioMap
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI Drug Target Discovery Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI Drug Target Discovery Service Market Size by Region (2021-2032)
- 1.4.1 Global AI Drug Target Discovery Service Market Size by Region (2021-2026)
- 1.4.2 Global AI Drug Target Discovery Service Market Size by Region (2027-2032)
- 1.5 Key Regions AI Drug Target Discovery Service Market Size (2021-2032)
- 1.5.1 North America AI Drug Target Discovery Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI Drug Target Discovery Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI Drug Target Discovery Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI Drug Target Discovery Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI Drug Target Discovery Service Market Size Growth Rate (2021-2032)
2 AI Drug Target Discovery Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Target Identification Based on Omics Data and Biological Networks
- 2.1.2 Target Mining Based on Literature and Knowledge Graphs
- 2.1.3 Target Prediction Based on Structural Bioinformatics
- 2.1.4 Target Discovery Based on Phenotypic Screening and Virtual Patients
- 2.2 Global AI Drug Target Discovery Service Market Size by Type
- 2.2.1 Global AI Drug Target Discovery Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI Drug Target Discovery Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI Drug Target Discovery Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI Drug Target Discovery Service Market Size by Regions
- 2.3.1 North America AI Drug Target Discovery Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI Drug Target Discovery Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI Drug Target Discovery Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI Drug Target Discovery Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI Drug Target Discovery Service Market Size Breakdown by Type (2021-2026)
3 AI Drug Target Discovery Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Company
- 3.1.2 CRO and Universities
- 3.1.3 Others
- 3.2 Global AI Drug Target Discovery Service Market Size by Application
- 3.2.1 Global AI Drug Target Discovery Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI Drug Target Discovery Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI Drug Target Discovery Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI Drug Target Discovery Service Market Size by Regions
- 3.3.1 North America AI Drug Target Discovery Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI Drug Target Discovery Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI Drug Target Discovery Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI Drug Target Discovery Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI Drug Target Discovery Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI Drug Target Discovery Service Industry Trends
- 4.2 AI Drug Target Discovery Service Industry Drivers
- 4.3 AI Drug Target Discovery Service Industry Opportunities and Challenges
- 4.4 AI Drug Target Discovery Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI Drug Target Discovery Service Revenue (2021-2026)
- 5.2 Global AI Drug Target Discovery Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI Drug Target Discovery Service Key Company Headquarters & Area Served
- 5.4 Global AI Drug Target Discovery Service Company, Product Type & Application
- 5.5 Global AI Drug Target Discovery Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI Drug Target Discovery Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI Drug Target Discovery Service Players Market Share by Revenue in 2025
- 5.6.3 2025 AI Drug Target Discovery Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Exscientia
- 6.1.1 Exscientia Company Information
- 6.1.2 Exscientia Business Overview
- 6.1.3 Exscientia AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Exscientia AI Drug Target Discovery Service Product Portfolio
- 6.1.5 Exscientia Recent Developments
- 6.2 Atomwise
- 6.2.1 Atomwise Company Information
- 6.2.2 Atomwise Business Overview
- 6.2.3 Atomwise AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Atomwise AI Drug Target Discovery Service Product Portfolio
- 6.2.5 Atomwise Recent Developments
- 6.3 Benevolent AI
- 6.3.1 Benevolent AI Company Information
- 6.3.2 Benevolent AI Business Overview
- 6.3.3 Benevolent AI AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Benevolent AI AI Drug Target Discovery Service Product Portfolio
- 6.3.5 Benevolent AI Recent Developments
- 6.4 Insitro
- 6.4.1 Insitro Company Information
- 6.4.2 Insitro Business Overview
- 6.4.3 Insitro AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Insitro AI Drug Target Discovery Service Product Portfolio
- 6.4.5 Insitro Recent Developments
- 6.5 Xaira Therapeutics
- 6.5.1 Xaira Therapeutics Company Information
- 6.5.2 Xaira Therapeutics Business Overview
- 6.5.3 Xaira Therapeutics AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Xaira Therapeutics AI Drug Target Discovery Service Product Portfolio
- 6.5.5 Xaira Therapeutics Recent Developments
- 6.6 Tempus AI
- 6.6.1 Tempus AI Company Information
- 6.6.2 Tempus AI Business Overview
- 6.6.3 Tempus AI AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Tempus AI AI Drug Target Discovery Service Product Portfolio
- 6.6.5 Tempus AI Recent Developments
- 6.7 AbCellera
- 6.7.1 AbCellera Company Information
- 6.7.2 AbCellera Business Overview
- 6.7.3 AbCellera AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 AbCellera AI Drug Target Discovery Service Product Portfolio
- 6.7.5 AbCellera Recent Developments
- 6.8 Recursion
- 6.8.1 Recursion Company Information
- 6.8.2 Recursion Business Overview
- 6.8.3 Recursion AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Recursion AI Drug Target Discovery Service Product Portfolio
- 6.8.5 Recursion Recent Developments
- 6.9 Iktos
- 6.9.1 Iktos Company Information
- 6.9.2 Iktos Business Overview
- 6.9.3 Iktos AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Iktos AI Drug Target Discovery Service Product Portfolio
- 6.9.5 Iktos Recent Developments
- 6.10 Genialis
- 6.10.1 Genialis Company Information
- 6.10.2 Genialis Business Overview
- 6.10.3 Genialis AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Genialis AI Drug Target Discovery Service Product Portfolio
- 6.10.5 Genialis Recent Developments
- 6.11 Anima Biotech
- 6.11.1 Anima Biotech Company Information
- 6.11.2 Anima Biotech Business Overview
- 6.11.3 Anima Biotech AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Anima Biotech AI Drug Target Discovery Service Product Portfolio
- 6.11.5 Anima Biotech Recent Developments
- 6.12 BPGbio
- 6.12.1 BPGbio Company Information
- 6.12.2 BPGbio Business Overview
- 6.12.3 BPGbio AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 BPGbio AI Drug Target Discovery Service Product Portfolio
- 6.12.5 BPGbio Recent Developments
- 6.13 Cradle
- 6.13.1 Cradle Company Information
- 6.13.2 Cradle Business Overview
- 6.13.3 Cradle AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Cradle AI Drug Target Discovery Service Product Portfolio
- 6.13.5 Cradle Recent Developments
- 6.14 Isomorphic Labs
- 6.14.1 Isomorphic Labs Company Information
- 6.14.2 Isomorphic Labs Business Overview
- 6.14.3 Isomorphic Labs AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Isomorphic Labs AI Drug Target Discovery Service Product Portfolio
- 6.14.5 Isomorphic Labs Recent Developments
- 6.15 Generate Biomedicines
- 6.15.1 Generate Biomedicines Company Information
- 6.15.2 Generate Biomedicines Business Overview
- 6.15.3 Generate Biomedicines AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Generate Biomedicines AI Drug Target Discovery Service Product Portfolio
- 6.15.5 Generate Biomedicines Recent Developments
- 6.16 Latent Labs
- 6.16.1 Latent Labs Company Information
- 6.16.2 Latent Labs Business Overview
- 6.16.3 Latent Labs AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Latent Labs AI Drug Target Discovery Service Product Portfolio
- 6.16.5 Latent Labs Recent Developments
- 6.17 Relay Therapeutics
- 6.17.1 Relay Therapeutics Company Information
- 6.17.2 Relay Therapeutics Business Overview
- 6.17.3 Relay Therapeutics AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Relay Therapeutics AI Drug Target Discovery Service Product Portfolio
- 6.17.5 Relay Therapeutics Recent Developments
- 6.18 Model Medicines
- 6.18.1 Model Medicines Company Information
- 6.18.2 Model Medicines Business Overview
- 6.18.3 Model Medicines AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Model Medicines AI Drug Target Discovery Service Product Portfolio
- 6.18.5 Model Medicines Recent Developments
- 6.19 Nimbus Therapeutics
- 6.19.1 Nimbus Therapeutics Company Information
- 6.19.2 Nimbus Therapeutics Business Overview
- 6.19.3 Nimbus Therapeutics AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Nimbus Therapeutics AI Drug Target Discovery Service Product Portfolio
- 6.19.5 Nimbus Therapeutics Recent Developments
- 6.20 Schrödinger
- 6.20.1 Schrödinger Company Information
- 6.20.2 Schrödinger Business Overview
- 6.20.3 Schrödinger AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Schrödinger AI Drug Target Discovery Service Product Portfolio
- 6.20.5 Schrödinger Recent Developments
- 6.21 XtalPi
- 6.21.1 XtalPi Company Information
- 6.21.2 XtalPi Business Overview
- 6.21.3 XtalPi AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 XtalPi AI Drug Target Discovery Service Product Portfolio
- 6.21.5 XtalPi Recent Developments
- 6.22 Insilico Medicine
- 6.22.1 Insilico Medicine Company Information
- 6.22.2 Insilico Medicine Business Overview
- 6.22.3 Insilico Medicine AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Insilico Medicine AI Drug Target Discovery Service Product Portfolio
- 6.22.5 Insilico Medicine Recent Developments
- 6.23 Drug Farm
- 6.23.1 Drug Farm Company Information
- 6.23.2 Drug Farm Business Overview
- 6.23.3 Drug Farm AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Drug Farm AI Drug Target Discovery Service Product Portfolio
- 6.23.5 Drug Farm Recent Developments
- 6.24 BioMap
- 6.24.1 BioMap Company Information
- 6.24.2 BioMap Business Overview
- 6.24.3 BioMap AI Drug Target Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.24.4 BioMap AI Drug Target Discovery Service Product Portfolio
- 6.24.5 BioMap Recent Developments
7 North America
- 7.1 North America AI Drug Target Discovery Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI Drug Target Discovery Service Market Size by Country (2021-2026)
- 7.3 North America AI Drug Target Discovery Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI Drug Target Discovery Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI Drug Target Discovery Service Market Size by Country (2021-2026)
- 8.3 Europe AI Drug Target Discovery Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI Drug Target Discovery Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI Drug Target Discovery Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI Drug Target Discovery Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI Drug Target Discovery Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI Drug Target Discovery Service Market Size by Country (2021-2026)
- 10.3 South America AI Drug Target Discovery Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI Drug Target Discovery Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI Drug Target Discovery Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI Drug Target Discovery Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst